Balance Sheet for Halozyme Therapeutics Inc. (HALO)

$ 30.22   0.76 (+2.58%) Volume: 3.4m 4:00 PM EDT Oct 20, 2020
After Hours:  $ 30.70   0.48 (+1.59%) Volume: 21.08k 7:19 PM EDT Oct 20, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 120,179 57,936 168,740 66,764 43,292
Restrictable Cash - - - - -
Marketable Securities 301,083 296,590 300,474 138,217 65,047
Accounts Receivable 59,442 30,005 22,133 15,680 32,410
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 59,442 30,005 22,133 15,680 32,410
Inventories, Raw Materials 2,769 735 377 761 677
Inventories, Work in Progress 15,710 11,430 2,131 12,850 8,481
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 10,880 10,460 2,638 1,012 331
Inventories, Other 29,359 22,625 5,146 14,623 9,489
Inventories, Adjustments & Allowances - - - - -
Inventories 29,359 22,625 5,146 14,623 9,489
Prepaid Expenses 33,373 20,693 13,879 21,248 21,534
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 543,436 427,849 510,372 256,532 171,772
Land and Improvements - - - - -
Buildings and Improvement 1,628 4,569 2,715 2,331 2,025
Machinery, Furniture and Equipment 16,120 19,135 14,695 13,852 12,236
Construction in Progress - - - - -
Fixed Assets, Other 3,849 - - - -
Fixed Assets, Total 21,597 23,704 17,410 16,183 14,261
Gross Fixed Assets 21,597 23,704 17,410 16,183 14,261
Accumulated Depreciation (10,742) (16,239) (13,890) (11,919) (10,318)
Net Fixed Assets 10,855 7,465 3,520 4,264 3,943
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 500 500 500 500 500
Total Non-Current Assets 22,438 12,399 9,573 4,983 10,017
Total Assets 565,874 440,248 519,945 261,515 181,789
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 6,434 4,079 7,948 3,578 4,499
Short Term Debt 19,542 91,506 77,211 17,393 21,862
Notes Payable - - - - -
Accrued Expenses 55,649 49,529 39,601 28,821 26,792
Accrued Liabilities 55,649 49,529 39,601 28,821 26,792
Deferred Revenues 4,012 4,247 6,568 4,793 9,304
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities 85,637 149,361 131,328 54,585 62,457
Long Term Debt 383,045 34,874 125,140 199,228 27,971
Deferred Income Tax 1,247 5,008 54,297 39,825 43,919
Other Non-Current Liabilities 5,427 7,126 55,111 40,183 48,362
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 388,472 42,000 180,251 239,411 76,333
Total Liabilities 474,109 191,361 311,579 293,996 138,790
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 91,765 248,887 208,366 (32,481) 42,999
Common Par 137 145 143 130 128
Additional Paid in Capital 695,066 780,457 731,044 552,737 525,628
Cumulative Translation Adjustments - - - - -
Retained Earnings (603,678) (531,438) (522,371) (585,342) (482,658)
Treasury Stock - - - - -
Other Equity Adjustments 240 (277) (450) (6) (99)
Total Capitalization 474,810 283,761 333,506 166,747 70,970
Total Equity 91,765 248,887 208,366 (32,481) 42,999
Total Liabilities & Shareholder's Equity 565,874 440,248 519,945 261,515 181,789
Cash Flow (73,839) (79,628) 61,113 (105,985) (34,787)
Working Capital 457,799 278,488 379,044 201,947 109,315
Free Cash Flow (89,463) (54,163) 132,703 (53,520) (39,443)
Invested Capital 474,810 283,761 333,506 166,747 70,970
Shares Outstanding - Common Class Only 136,713 144,725 142,789 129,502 128,152
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 136,713 144,725 142,789 129,502 128,152
Total Common Shares Outstanding 136,713 144,725 142,789 129,502 128,152
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 144,329 143,599 136,419 127,964 126,704
Diluted Weighted Shares Outstanding 144,329 143,599 139,068 127,964 126,704